GLOME Holdings, Inc. (8938) Income statement

Market cap

¥2.8B

P/E ratio

-6.9x

Glome Holdings supports medical institutions across Japan with management guidance, equipment sales, and international patient services while operating declining real estate assets in Hokkaido.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03
Revenue	6,415	7,420	6,101	6,486	6,885	6,946	13,774	14,829	8,288	3,968	2,470	1,798	1,238	2,043
Revenue growth (%)	-
Cost of revenue	-	-	-	4,841	5,322	4,966	10,066	11,184	6,267	2,659	905	630	374	1,070
Gross profit	-	-	-	1,645	1,563	1,980	3,708	3,644	2,020	1,309	1,564	1,167	863	972
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	1,282	1,346	1,355	2,204	2,282	2,627	931	1,223	1,078	1,008	1,018
Operating income	-	-	-	363	217	625	1,504	1,361	-606	377	340	89	-144	-46
Income before tax	-28	148	277	33	-360	591	1,050	1,502	-2,219	46	346	268	-192	-53
Pretax margin (%)	-0.4	2	4.5	0.5	-5.2	8.5	7.6	10.1	-26.8	1.2	14	14.9	-15.5	-2.6
Provision for income taxes	-	-	-	100	407	136	217	558	263	-16	126	40	13	27
Effective tax rate (%)	-	-	-
Net income	-37	213	270	321	1,240	-285	450	1,003	-2,227	-255	220	350	-198	70
Net income margin (%)
Earnings per share	44.49	69.02	116.63	135.73	507.78	-51.22	47.37	180.46	-400.62	-38.82	23.09	38.47	-21.91	7.82
Diluted EPS	-	-	-	-	-	-	-	-	-	172.74	23.08	-	5.02	-
Dividend payout ratio (%)	-	-	-	-	-	-	-	-	-	-		-	-	-
Dividend per share	-	-	-	-	-	-	-	-	-	-	6	5	-	2
EBITDA	-	-	-
EBITDA margin (%)	-	-	-